TickerFacts.

Vericel Corp (VCEL): Cost of Revenue

Annual figures by period end, from SEC filings.

$70.66M
Year ended 2025-12-31
$77.92M
Trailing 12 months to 2026-06-30
+9.0%
3-year compound annual growth
+12.1%
5-year compound annual growth
+10.3%
10-year compound annual growth
2009-06-30: $112.0K2010-06-30: $34.0K2011-12-31: $4.0K2012-12-31: $6.0K2013-12-31: $4.0K2014-12-31: $17.29M2015-12-31: $26.47M2016-12-31: $28.31M2017-12-31: $30.35M2018-12-31: $32.16M2019-12-31: $37.57M2020-12-31: $39.95M2021-12-31: $50.16M2022-12-31: $54.58M2023-12-31: $61.94M2024-12-31: $65.12M2025-12-31: $70.66M$70.66M
2009-06-30 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$70.66M+8.5%2026-02-26, From 2025-01-01
2024-12-31$65.12M+5.1%2026-02-26, From 2024-01-01
2023-12-31$61.94M+13.5%2026-02-26, From 2023-01-01
2022-12-31$54.58M+8.8%2025-02-27, From 2022-01-01
2021-12-31$50.16M+25.6%2024-02-29, From 2021-01-01
2020-12-31$39.95M+6.3%2023-02-23, From 2020-01-01
2019-12-31$37.57M+16.8%2022-02-24, From 2019-01-01
2018-12-31$32.16M+5.9%2021-02-24, From 2018-01-01
2017-12-31$30.35M+7.2%2020-02-25, From 2017-01-01
2016-12-31$28.31M+6.9%2019-02-26, From 2016-01-01
2015-12-31$26.47M+53.1%2018-03-05, From 2015-01-01
2014-12-31$17.29Mn/m2017-03-13, From 2014-01-01
2013-12-31$4.0K-33.3%2016-03-14, From 2013-01-01
2012-12-31$6.0K+50.0%2015-03-25, From 2012-01-01
2011-12-31$4.0Kn/a2014-03-13, From 2011-01-01
No annual figure between 2010-06-30 and 2011-12-31.
2010-06-30$34.0K-69.6%2013-03-18, From 2009-07-01
2009-06-30$112.0Kn/a2012-03-15, From 2008-07-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Vericel Corp (VCEL)2025-12-31$70.66M+8.5%
Adaptive Biotechnologies Corp (ADPT)2025-12-31$71.36M-1.0%
Iovance Biotherapeutics, Inc. (IOVA)2025-12-31$173.18M+85.7%
Twist Bioscience Corp (TWST)2025-09-30$185.57M+3.3%
Immunocore Holdings plc (IMCR)2025-12-31$5.09M+86.3%
Adaptimmune Therapeutics PLC (ADAPY)2024-12-31$70.0Kn/a
REGENXBIO Inc. (RGNX)2024-12-31$33.57M-9.8%
ADMA Biologics, Inc. (ADMA)2025-12-31$217.41M+5.1%
Agenus Inc (AGEN)2025-12-31$1.02M+110.3%

Compare VCEL, ADPT, IOVA, TWST side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗